CONSOLIDATED STATEMENT OF CASH FLOWS (USD $)	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Cash flows from operating activities:
Net income	$ 3,354,000,000	$ 2,998,000,000
Less: Net income attributable to the noncontrolling interest	71,000,000	21,000,000
Net income attributable to Honeywell	3,283,000,000	2,977,000,000
Adjustments to reconcile net income attributable to Honeywell to net cash provided by operating activities:
Depreciation and amortization	698,000,000	740,000,000
Loss on sale of non-strategic businesses and assets	11,000,000	0
Gain on sale of available for sale investments	(105,000,000)	0
Repositioning and other charges	453,000,000	419,000,000
Net payments for repositioning and other charges	(301,000,000)	(517,000,000)
Pension and other postretirement income	(150,000,000)	(61,000,000)
Pension and other postretirement benefit payments	(123,000,000)	(253,000,000)
Stock compensation expense	143,000,000	129,000,000
Deferred income taxes	255,000,000	257,000,000
Excess tax benefits from share based payment arrangements	(71,000,000)	(101,000,000)
Other	(207,000,000)	35,000,000
Changes in assets and liabilities, net of the effects of acquisitions and divestitures:
Accounts, notes and other receivables	(529,000,000)	(382,000,000)
Inventories	(279,000,000)	(94,000,000)
Other current assets	181,000,000	(28,000,000)
Accounts payable	154,000,000	(32,000,000)
Accrued liabilities	(151,000,000)	(422,000,000)
Net cash provided by operating activities	3,262,000,000	2,667,000,000
Cash flows from investing activities:
Expenditures for property, plant and equipment	(680,000,000)	(547,000,000)
Proceeds from disposals of property, plant and equipment	12,000,000	7,000,000
Increase in investments	(3,139,000,000)	(703,000,000)
Decrease in investments	2,124,000,000	648,000,000
Cash paid for acquisitions, net of cash acquired	(4,000,000)	(1,063,000,000)
Proceeds from sales of businesses, net of fees paid	157,000,000	0
Other	(109,000,000)	104,000,000
Net cash used for investing activities	(1,639,000,000)	(1,554,000,000)
Cash flows from financing activities:
Net increase in commercial paper	550,000,000	1,699,000,000
Net (decrease) increase in short-term borrowings	(5,000,000)	18,000,000
Proceeds from issuance of common stock	206,000,000	362,000,000
Proceeds from issuance of long-term debt	79,000,000	27,000,000
Payments of long-term debt	(607,000,000)	(604,000,000)
Excess tax benefits from share based payment arrangements	71,000,000	101,000,000
Repurchases of common stock	(689,000,000)	(769,000,000)
Cash dividends paid	(1,101,000,000)	(995,000,000)
Other	(7,000,000)	28,000,000
Net cash used for financing activities	(1,503,000,000)	(133,000,000)
Effect of foreign exchange rate changes on cash and cash equivalents	(114,000,000)	(115,000,000)
Net increase in cash and cash equivalents	6,000,000	865,000,000
Cash and cash equivalents at beginning of period	6,422,000,000	4,634,000,000
Cash and cash equivalents at end of period	$ 6,428,000,000	$ 5,499,000,000